NeoGenomics to Attend Morgan Stanley’s 22nd Annual Global Healthcare Conference

NeoGenomics, Inc. (NASDAQ: NEO), Morgan Stanley, Inc., a leading oncology testing services company, will attend Morgan Stanley’s 22nd Annual Global Healthcare Conference. Chris Smith, Chief Executive Officer, Jeff Sherman, Chief Financial Officer, and Warren Stone, Chief Commercial Officer, will participate in an in-person fireside chat on Friday, September 6, 2024 at 10:45 a.m. ET in New York City.

The presentation will be broadcast live and accessible online via this link. A replay will be available on the Investor Relations section of the Company’s website at ir.neogenomics.com.